Allison B Goldfine (Allison Goldfine)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 3

Top Topics

Placebo Controlled

Top Venues

The Journal of clinical endocrinology and metabolism

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

William B Smith, David Nguyen, Timothy Clough, Jül Schofield, Mark R Kagan, Jill Kompa, Yan-Ling He, Eleftheria Maratos-Flier, Joanna Jamontt, Linh Vong, Chad D Schwartzkopf, Joseph D Layne, Aimee R Usera, Christopher J O'Donnell, Kurt A Heldwein, Ryan S Streeper, Allison B Goldfine
A growth-differentiation factor 15 receptor agonist in randomized placebo-controlled trials in healthy or obese persons. The Journal of clinical endocrinology and metabolism (2024)
Daniel James Rader, Eleftheria Maratos-Flier, Amanda Nguyen, Douglas Hom, Michael Ferriere, Yifang Li, Jill Kompa, Miljen Martic, Markus Hinder, Craig T Basson, David Yowe, John L Diener, Allison B Goldfine, null null
LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in obese adults with modest hypertriglyceridemia. The Journal of clinical endocrinology and metabolism (2021)
Jonathan M Dreyfuss, Yixing Yuchi, Xuehong Dong, Vissarion Efthymiou, Hui Pan, Donald C Simonson, Ashley Vernon, Florencia Halperin, Pratik Aryal, Anish Konkar, Yinong Sebastian, Brandon W Higgs, Joseph Grimsby, Cristina M Rondinone, Simon Kasif, Barbara B Kahn, Kathleen Foster, Randy J Seeley, Allison B Goldfine, Vera Djordjilović, Mary Elizabeth Patti
High-throughput mediation analysis of human proteome and metabolome identifies mediators of post-bariatric surgical diabetes control. Nature communications 12 (1) (2021)